|
SR-B1
|
Cholesterol efflux, clears SAA
|
Tomita et al. (2015); He et al. (2003, 2006); Ye and Sun (2017); van der Westhuyzen et al. (2005); Cai et al. (2005)
|
|
FPRL1
|
Stimulates MMP-9
|
Badolato et al. (1994, 1995); Gao and Murphy (1993); Fiore et al. (1994); Su et al. (1999); Patel et al. (1998); Furlaneto and Campa (2000); Dufton et al. (2010); Ji et al. (2015)
|
|
FPR2
|
Phagocyte migration; antiapoptotic
|
de Buck et al. (2016); Gao and Murphy (1993); Furlaneto and Campa (2000); Ye and Sun (2017); Chen et al. (2014)
|
|
TLR2
|
Induce IRZF7, IRF4-jmjd3; M2 markers (IL-33, IL-10, IL-1m)
|
de Buck et al. (2016); Ray et al. (2006); He et al. (2006, 2007); Cheng et al. (2008); Ji et al. (2015); Ye and Sun (2017); Rosenthal et al. (1976); Chen and Moller (2010)
|
|
TLR4
|
Activate NF-κB, AP-1→NOS
|
Hiratsuka et al. (2008); de Buck et al. (2016); Sandri et al. (2008); Deguchi et al. (2013); Li et al. (2015); Ye and Sun (2017); Poltorak et al. (1998)
|
|
RAGE
|
Activate NF-κB, induce cytokines
|
Li et al. (2015); Yan et al. (2000); Rὄcken et al. (2003); Kennel et al. (2016); Ye and Sun (2017)
|
|
Bacteria
|
Opsonize Gram negative species
|
Hari-Dass et al. (2005); Shah et al. (2006); Ye and Sun (2017)
|
